A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Recruiting now · Phase 3
Conditions studied: Breast Cancer
In brief
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Key facts
- Study ID
- NCT06492616
- Run by
- Stemline Therapeutics, Inc.
- People needed
- 4220
- Starts
- 2024-09-27
- Expected to finish
- 2032-10-01
- Last updated by the study team
- 2026-07-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ironwood Cancer and Research Centers — Chandler, Arizona, United States (enrolling)
- Banner MD Anderson Cancer Center — Gilbert, Arizona, United States (enrolling)
- Mayo Clinic — Scottsdale, Arizona, United States (enrolling)
- Arizona Clinical Research Center, Inc. — Tucson, Arizona, United States (enrolling)
- University of Arizona Cancer Center — Tucson, Arizona, United States (enrolling)
- Highlands Oncology Group, PA — Springdale, Arkansas, United States (enrolling)
- Comprehensive Blood & Cancer Center — Bakersfield, California, United States (enrolling)
- UCSF Cancer Center Berkeley — Berkeley, California, United States (enrolling)
- Cedars-Sinai Cancer Beverly Hills — Beverly Hills, California, United States (enrolling)
- City of Hope National Medical Center — Duarte, California, United States (enrolling)
- UCSF Wash Cancer CNTR — Fremont, California, United States (enrolling)
- City of Hope at Irvine Lennar — Irvine, California, United States (enrolling)
- UC San Diego Moores Cancer Center — La Jolla, California, United States (enrolling)
- Helios Clinical Research — Long Beach, California, United States (enrolling)
- Cancer and Blood Research Center, LLC — Los Alamitos, California, United States (enrolling)
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States (enrolling)
- UCLA Department of Medicine - Hematology/Oncology — Los Angeles, California, United States (enrolling)
- Pacific Cancer Care - Oncology — Monterey, California, United States (enrolling)
- Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States (enrolling)
- UC Irvine Health, Chao Family Comprehensive Cancer Center — Orange, California, United States (enrolling)
- Stanford Women's Cancer Center — Palo Alto, California, United States (enrolling)
- Dignity Health dba Health Research Institute — Sacramento, California, United States (enrolling)
- Sutter Institute for Medical Research — Sacramento, California, United States (enrolling)
- UCSF Zuckerberg SF General — San Francisco, California, United States (enrolling)
- Southern Cancer Center, PC — Daphne, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.